Is bladder biopsy necessary at three or six months post BCG therapy?
- 30 June 2003
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 21 (3) , 207-209
- https://doi.org/10.1016/s1078-1439(02)00239-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy—part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-upUrology, 2001
- The management of superficial bladder cancerBJU International, 2001
- MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDYJournal of Urology, 2000
- IS TRANSURETHRAL BIOPSY OF THE BLADDER NECESSARY AFTER 3 MONTHS TO EVALUATE RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPY?Journal of Urology, 1999
- The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year OutcomeJournal of Urology, 1997
- The Relationship Among Multiple Recurrences, Progression and Prognosis of Patients with Stages TA and T1 Transitional Cell Cancer of the Bladder Followed for at least 20 yearsJournal of Urology, 1995
- Superficial Bladder Cancer Treated with Bacillus Calmette-Guerin: A Multivariate Analysis of Factors Affecting Tumor ProgressionJournal of Urology, 1989